Session Summary
The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.
Presenters
Douglas MacFadden
Chief Informatics Officer
Harvard Catalyst
Nich Wattanasin, MS
Corporate Team Lead
Partners HealthCare
Jack London, PhD
Research Professor Cancer Biology
Thomas Jefferson University
Director, Informatics Shared Resource
Sidney Kimmel Cancer Center
Kavi Wagholikar, PhD
Assistant in Computer Science
Massachusetts General Hospital
Presentations (4)
Presentation 1: SHRINE Update
- Review of all the new features added to the SHRINE Software
Presentation 2: Feasibility Studies Using SHRINE and i2b2
- New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.
Presentation 3:
Presentation 4: SMART on FHIR on i2b2